Funding
← Back to your selection

Andera Partners

Activity from announced rounds

Activity in this selectionOct 20, 2026 · Sep 21, 2026
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$91.7M
1 disclosed · full round size, not this investor’s share

By stage

Series C+1
Undisclosed1

By primary sector

Biotech1
Healthtech1

By country

France1
Switzerland1

Rounds

2 in this selection
Nouscom

Clinical-stage biotech developing neoantigen-based cancer immunotherapies.

€120MSeries D
Participant
HighLife

HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.

€80MFinancing round
Lead